Investing Profile

Amir Nashat

VCInvestor

Managing Partner at Polaris Partners

polarispartners.com/partner/a...Cambridge, Massachusetts
Photo of Amir Nashat, Managing Partner at Polaris Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Polaris Partners Managing Partner
$300K - $2.0M
$500K
46
$4B
CompanyStageDateRound SizeTotal Raised
Dewpoint Therapeutics
Series CFeb 2022$150M
Series BSep 2020$77M
$230M
Co-investors: Kristina Burow (ARCH Venture Partners)
Freenome
Series DDec 2021$300M
Series CAug 2020$270M
Series BJul 2019$160M
Series AAug 2017$7M
Series AMar 2017$65M
$800M
Co-investors: Bill Maris (Section 32), Skip Fleshman (Asset Management Ventures), Jeffrey Schwartz (Bain Capital Life Sciences), Vasudev Bailey (Artis Ventures (AV))
Kojin Therapeutics
Series AJun 2021$60M
$60M
Primmune Therapeutics
Series AOct 2020$27M
$27M
Jnana
Series ADec 2017$50M
$50M
Co-investors: Carlo Rizzuto (Versant Ventures), Kevin Kinsella (Avalon Ventures)
Jnana Therapeutics
Series ADec 2017$50M
$50M
Scholar Rock
Series BJan 2016$36M
Series ASep 2014$20M
$100M
Co-investors: Timothy A. Springer
Selecta Biosciences
Series ESep 2015$38M
Private Equity RoundOct 2014$20M
Series CApr 2010$15M
Series BFeb 2009$15M
$88M
Co-investors: Aymeric Sallin (NanoDimension), Carl Gordon (OrbiMed), Doug Cole (Flagship Ventures), Timothy A. Springer